The company's last investment was a Series B funding round which raised significant capital on 28 December 2022. The funding was led by SPDB International Holdings, a key player in the investment realm.
b-ONE offers a range of products including the MOBIO Total Knee System, KOSMO Stem, JUVENO Stem, and PRIMO Acetabular System. The startup's ultimate objective is to enable more patients globally to regain their active lifestyle utilizing the most advanced healthcare solutions available.
With a focus on innovation and improving healthcare economic value, b-ONE Ortho, Corp. presents an intriguing opportunity for potential investors operating within the healthcare and manufacturing sectors.
No recent news or press coverage available for b-ONE Ortho, Corp..